Digest Network Come funziona
Network
/
Società
Fo
Non verificato

Fortrea Holdings Inc

Di cosa scriviamo

Annunci EconomiciBiotecnologiaManagement/Organizzazione AziendaleMedicina Salute Benessere

16 comunicati stampa

Guarda tutti i comunicati
07/04/2026
Biotecnologia
Annunci Economici
Fortrea presenta Fortrea Intelligent Technology™ para ayudar a patrocinadores y centros de investigación a conducir ensayos clínicos más inteligentes e integradas
Fonte
Fortrea Holdings Inc
Emittente
GLOBENEWSWIRE
1.00
0
07/04/2026
Biotecnologia
Annunci Economici
Fortrea dévoile Fortrea Intelligent Technology™ : une technologie destinée à permettre aux investigateurs et aux centres d’essais cliniques de mener des essais plus intelligents et mieux intégrés
Fonte
Fortrea Holdings Inc
Emittente
GLOBENEWSWIRE
1.00
0
07/04/2026
Biotecnologia
Annunci Economici
Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated Trials
Fonte
Fortrea Holdings Inc
Emittente
GLOBENEWSWIRE
1.00
0
17/02/2026
Biotecnologia
Fortrea renforce son équipe de direction en nommant Oren Cohen au poste de directeur médical et Scott Dove à celui de président des services de pharmacologie clinique
Fonte
Fortrea Holdings Inc
Emittente
GLOBENEWSWIRE
1.00
0
17/02/2026
Biotecnologia
Fortrea amplía su equipo ejecutivo y nombra a Oren Cohen como Director Médico y a Scott Dove como Presidente de Servicios de Farmacología Clínica
Fonte
Fortrea Holdings Inc
Emittente
GLOBENEWSWIRE
1.00
0
17/02/2026
Biotecnologia
Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services
Fonte
Fortrea Holdings Inc
Emittente
GLOBENEWSWIRE
1.00
0
29/01/2026
Biotecnologia
Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call
Fonte
Fortrea Holdings Inc
Emittente
GLOBENEWSWIRE
1.00
0
24/06/2025
Biotecnologia
Medicina Salute Benessere
Management/Organizzazione Aziendale
Fortrea et Emery Pharma annoncent une collaboration stratégique visant à mener des études sur les interactions médicamenteuses répondant aux normes de la FDA en utilisant la rifampicine
Fonte
Fortrea Holdings Inc
Emittente
GLOBENEWSWIRE
1.00
0
24/06/2025
Biotecnologia
Medicina Salute Benessere
Management/Organizzazione Aziendale
Fortrea y Emery Pharma anuncian colaboración estratégica para realizar estudios de interacción fármaco-fármaco que cumplan con la FDA utilizando rifampicina
Fonte
Fortrea Holdings Inc
Emittente
GLOBENEWSWIRE
1.00
0
24/06/2025
Biotecnologia
Medicina Salute Benessere
Management/Organizzazione Aziendale
Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin
Fonte
Fortrea Holdings Inc
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0